$0.00
(0.00%
) Quote details
USD
( 0.00%
At Close (As of Jan 1, 1970)
$2.07B
Market Cap
-
P/E Ratio
-0.85
EPS
$28.49
52 Week High
$9.03
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Zymeworks Inc. is a Vancouver-based clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative biotherapeutics targeting cancer. Leveraging its proprietary platforms, the company has established a diverse pipeline that includes antibody-drug conjugates and bispecific therapeutics, aimed at addressing significant unmet medical needs in oncology. With a strong focus on advancing targeted therapies and strategic collaborations, Zymeworks is well-positioned to emerge as a pivotal player in the biopharmaceutical landscape, driving the delivery of transformative treatments to patients.
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
WBD
AAL
BIYA
TSLA
CIFR
PFE
SNAP
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
DVLT
ADTX
GRAB
CAN
DNN
IBRX
RIOT
APLD
GOOG
IREN
RIG
AG
BAC
AMD
AMCR
SMR
TMC
CDE
PLTR
ITUB
AGNC
KDLY
T
AMC
NVO
MSTR
NFLX
SAND
HBAN
SHOT
LPTX
VHAI
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
WBD
AAL
BIYA
TSLA
CIFR
PFE
SNAP
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
DVLT
ADTX
GRAB
CAN
DNN
IBRX
RIOT
APLD
GOOG
IREN
RIG
AG
BAC
AMD
AMCR
SMR
TMC
CDE
PLTR
ITUB
AGNC
KDLY
T
AMC
NVO
MSTR
NFLX
SAND
HBAN
SHOT